E* Chi'mes conducts a journal product presentation with the East Avenue Medical Center Neurosciences Department.

E* Chi'mes recently had the opportunity to conduct a Journal Product Presentation with the esteemed Neurosciences Department of East Avenue Medical Center. This engagement provided a platform to share clinical insights and discuss evidence-based approaches in neurological care.

During the presentation, E* Chi'mes highlighted the clinical studies and real-world applications of NeuroAiD II (MLC901) and Tripgard, focusing on their roles in supporting stroke recovery, neuro-rehabilitation, and patient compliance. The discussion emphasized how these innovative solutions align with the current needs of healthcare professionals in delivering comprehensive, patient-centered neurological care.

Our collaboration with the East Avenue Medical Center Neurosciences Department reflects E* Chi'mes’ ongoing commitment to supporting the medical community through continuous education and the introduction of advanced therapeutic options that can enhance patient outcomes.

We are grateful for the opportunity to exchange knowledge and insights with such a dedicated team of medical professionals and look forward to continuing our partnership in advancing neurological healthcare.